Gene · 2923
Papers3,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting transglutaminase 2: pathways to celiac disease therapies. | Gastroenterol Rep (Oxf) | 2025 | 41048571 | PubTator, text mining | PubMed |
| Exploring the molecular mechanisms and immune cell responses in brucellosis: Insights from gene expression profiles and immune cell scores. | PLoS One | 2025 | 40996975 | PubTator, text mining | PubMed |
| Modulation of bioenergetic metabolism by PDIA3 inhibition prevents breast cancer cell adhesion to endothelial cells. | Biochem Pharmacol | 2025 | 40972733 | PubTator, text mining | PubMed |
| Identification and molecular mechanism of palmitoylation-related biomarkers in obstructive sleep apnea. | Front Neurol | 2025 | 40948653 | PubTator, text mining | PubMed |
| Role of circadian CLOCK signaling in cellular senescence. | Biogerontology | 2025 | 40900376 | PubTator, text mining | PubMed |
| Regulation of Tetraspanin CD63 in Chronic Myeloid Leukemia (CML): Single-Cell Analysis of Asymmetric Hematopoietic Stem Cell Division Genes. | Bioengineering (Basel) | 2025 | 40868343 | PubTator, text mining | PubMed |
| An engineered glioblastoma model yields macrophage-secreted drivers of invasion. | JCI Insight | 2025 | 40857405 | PubTator, text mining | PubMed |
| Immunotherapy resistance in non-small cell lung cancer: from mechanisms to therapeutic opportunities. | J Exp Clin Cancer Res | 2025 | 40849659 | PubTator, text mining | PubMed |
| Cell Surface Proteomics Reveals Hypoxia-Regulated Pathways in Cervical and Bladder Cancer. | Proteomes | 2025 | 40843709 | PubTator, text mining | PubMed |
| Spatial protein redistribution: wandering but not lost. | Cell Mol Life Sci | 2025 | 40839310 | PubTator, text mining | PubMed |
| Perturbation of calreticulin potentiates CD8+ T cell-mediated antitumor immunity. | J Exp Med | 2025 | 40833532 | PubTator, text mining | PubMed |
| Machine learning-based construction of Immunogenic cell death-related score for improving prognosis and personalized treatment in glioma. | Sci Rep | 2025 | 40830197 | PubTator, text mining | PubMed |
| The leader of the capsid protein from Feline calicivirus must be palmitoylated and form oligomers through disulfide bonds for efficient viral replication. | J Virol | 2025 | 40827917 | PubTator, text mining | PubMed |
| Plasma proteomic signature for preoperative prediction of microvascular invasion in HCC. | JHEP Rep | 2025 | 40823177 | PubTator, text mining | PubMed |
| PDIA3 rs2788, a risk factor for metabolic syndrome, interacted negatively with antihypertensive medications. | Sci Rep | 2025 | 40783618 | PubTator, text mining | PubMed |
| Combining label-free quantitative proteomics and 2D-DIGE to identify the potential targets of Sini Decoction acting on myocardial infarction. | Chin J Nat Med | 2025 | 40754370 | PubTator, text mining | PubMed |
| Evaluation of the gastrotolerability of ketoprofen, lysine, and gabapentin co-crystal administration in an in vitro model of gastric epithelium: a proteomic update. | PLoS One | 2025 | 40729375 | PubTator, text mining | PubMed |
| Vitamin D Reshapes Genomic Hierarchies in Skin Cells: lncRNA-Driven Responses in Carcinoma Versus Transcription Factor-Based Regulation in Healthy Skin. | Int J Mol Sci | 2025 | 40724881 | PubTator, text mining | PubMed |
| CALR Type 1-Like Mutations Increase Endoplasmic Reticulum Free Ca2+ and Induce ERK1/2 Activation Independent of Thrombopoietin Receptor Activation. | Cell Biol Int | 2025 | 40586641 | PubTator, text mining | PubMed |
| Effectiveness of Artificial Intelligence Models in Predicting Lung Cancer Recurrence: A Gene Biomarker-Driven Review. | Cancers (Basel) | 2025 | 40507370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2923/papers?page=4